Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.3K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

869
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
869
Development of Analytical Methods01:21

Development of Analytical Methods

524
An analytical methodology can be divided into four sequential steps: technique, method, procedure, and protocol. A technique is a scientific principle that rationalizes a specific phenomenon through chemical measurements. Adapting a technique for analyzing a sample of interest is termed a method. The procedure outlines the directions for performing the analysis via an analytical method. The protocol is the detailed guidelines on the procedure, which should be strictly followed to obtain the...
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Supervised Pre-Training with Intensity Guided Masking for Enhanced Aorta Segmentation in CT.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Brain Volume Correlations and Machine Learning Classification in Epilepsy Diagnosis.

Advances in experimental medicine and biology·2025
Same author

Deep Learning Discrimination for BCI Implementation Using 3D Convolutional Neural Network and EEG Topographic Maps.

Advances in experimental medicine and biology·2025
Same author

Machine Learning in Adolescent Mental Health: Advanced Comorbidity Analysis and Text Mining Insights.

Healthcare (Basel, Switzerland)·2025
Same author

Enhanced Machine Learning Approach to ADHD Classification Using Actigraphy Data.

Studies in health technology and informatics·2025
Same author

Machine Learning and Urinary Incontinence in Prostate Cancer: A Generalized Additive Model of Physical Activity and Recovery Patterns.

Studies in health technology and informatics·2025
Same journal

Osmolyte-Based Formulations for Enhanced Thermal Stability of mRNA Drug Substance: A Systematic Screening and Optimization Study.

Pharmaceutical research·2026
Same journal

Design, Synthesis and Characterization of Anti-CTLA4 Peptide Conjugated Gemcitabine Prodrug Nanoparticles for Targeted Lung Cancer Chemoimmunotherapy.

Pharmaceutical research·2026
Same journal

Leveraging Carnitine-functionalized Lipid Nanocarrier based Targeted Delivery of A1874 PROTAC for Glioblastoma.

Pharmaceutical research·2026
Same journal

Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.

Pharmaceutical research·2026
Same journal

Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis.

Pharmaceutical research·2026
Same journal

Spray Dried Lysozyme Microspheres: Morphological Evolution and Enzymatic Activity Retention.

Pharmaceutical research·2026
See all related articles

Related Experiment Video

Updated: Aug 18, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

Analytical Workflows to Unlock Predictive Power in Biotherapeutic Developability.

Markos Trikeriotis1, Sergey Akbulatov2, Umberto Esposito2

  • 1Research and Development, Malvern Panalytical Limited, Grovewood Road, Malvern, WR14 1XZ, Worcestershire, UK. markos.trikeriotis@malvernpanalytical.com.

Pharmaceutical Research
|December 5, 2022
PubMed
Summary
This summary is machine-generated.

This study integrates expert knowledge into data models for biopharmaceutical developability assays. New analytical workflows combining biophysical techniques and machine learning improve the prediction of molecular liabilities in monoclonal antibodies.

Keywords:
aggregationcolloidal stabilityconformational stabilitymachine learningmonoclonal antibody

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.8K

Related Experiment Videos

Last Updated: Aug 18, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.8K

Area of Science:

  • Biopharmaceutical Developability Assessment
  • Protein Biophysical Characterization
  • Machine Learning in Drug Discovery

Background:

  • Accurate data models are crucial for designing effective developability assays in biopharmaceutical development.
  • Incorporating domain expertise into modeling processes is essential for practical applications.
  • Existing workflows may overlook specific molecular liabilities in monoclonal antibodies (mAbs).

Purpose of the Study:

  • To enhance data modeling for developability assays by integrating expert knowledge.
  • To develop novel metrics from instrument data and guide the selection of input parameters and machine learning (ML) techniques.
  • To improve the understanding and prediction of molecular liabilities in mAbs.

Main Methods:

  • Generated datasets from biophysical characterization of five monoclonal antibodies (mAbs).
  • Explored combinations of techniques (e.g., Differential Scanning Calorimetry, Light Scattering) and parameters to identify those best describing molecular liabilities.
  • Employed machine learning algorithms to predict key metrics from the generated datasets.

Main Results:

  • Combined Differential Scanning Calorimetry and Light Scattering thermal ramps identified domain-specific aggregation in mAbs missed by standard workflows.
  • Analysis of responses to varying salt concentrations provided insights into colloidal stability, aligning with charge distribution models.
  • Machine learning successfully predicted Differential Scanning Calorimetry transition temperatures, with metric importance enhancing model explainability.

Conclusions:

  • Developed analytical workflows provide a superior description of molecular behavior and reveal connections between structural properties and liabilities.
  • The study establishes a foundation for leveraging machine learning's predictive capabilities in developability assessment.
  • Future integration of these insights with advanced ML algorithms promises to significantly enhance predictive power in biopharmaceutical development.